What is the NOAEL for 4-Hexylresorcinol?
4-Hexylresorcinol has 32 NOAEL studies in the database. The lowest reported value is 0 unitless. Source: NTP_ICE_endocrine.
Also known as: p-Hexylresorcinol, 1,3-Benzenediol, 4-hexyl-, 4-Hexyl-1,3-benzenediol, Hexylresorcinol, 4-06-00-06048 (+15 more)
CAS 136-77-6
4-Hexylresorcinol (CAS 136-77-6) is a chemical substance. Key regulatory status: REACH registered, 2 regulatory/inventory lists, cosmetic ingredient cross-reference; source data from EPA ToxValDB, EPA CPDat, AICIS, ECHA REACH.
4-Hexylresorcinol is classified GHS Danger (H302, H315, H319, H335, H360F) in the chemicals database but is allowed in EU cosmetics at max 20%.
CAS, identifiers, formula, and alternate names for the matched substance record.
Industrial and product-use categories associated with this substance.
Inventory, screening, and regulatory list matches from public chemical databases.
| List | Keyword | Source |
|---|---|---|
| Canada; pharmaceutical | DrugBank | DrugBank |
| Canada; consumer_product; Substances in Products - Canada (4/2014) | Government of Canada | CPCat |
Toxicology endpoints rendered from public NOAEL study rows.
| Value | Unit | Endpoint | Route | Species | Source |
|---|---|---|---|---|---|
| 16.8984160590701 | uM | AC50 | - | - | NTP_ICE_endocrine |
| 47.6085741 | uM | AC50 | - | - | NTP_ICE_endocrine |
| 10.5243823504332 | uM | ACC | - | - | NTP_ICE_endocrine |
| 63.2174484099999 | uM | ACC | - | - | NTP_ICE_endocrine |
| <=50 | mg/L | ADI | - | - | INCHEM_WHO_jecfa_jecmono_v35je04 |
| <=50 | mg/L | ADI | - | - | INCHEM_WHO_jecfa_jecmono_v35je04 |
| =4 | mg/kg bw/day | BMDL (10) | oral | Mouse | ToxValDB_EFSA |
| 227 | uL/min/10^6 cells | Clint | - | Rat | NTP_ICE_adme_parameters |
| R9QTB5E82N | UNII | FDA UNII substance identifier | - | - | openFDA substances |
| R9QTB5E82N | UNII | FDA UNII substance identifier | - | - | openFDA substances |
| R9QTB5E82N | UNII | FDA UNII substance identifier | - | - | openFDA substances |
| R9QTB5E82N | UNII | FDA UNII substance identifier | - | - | openFDA substances |
| =550 | mg/kg bw | LD50 | oral | Rat | NTP_ICE_acute_oral |
| =62.5 | mg/kg bw/day | LEL | oral | Mouse | ToxValDB_ToxRefDB |
| =62.5 | mg/kg bw/day | LEL | oral | mouse (b6c3f1; B6C3F1) | ToxRefDB_ToxRefDB_v3_pod.csv |
| >125 | mg/kg bw/day | LEL | oral | Rat | ToxValDB_ToxRefDB |
| >125 | mg/kg bw/day | LEL | oral | rat (fischer; Fischer 344) | ToxRefDB_ToxRefDB_v3_pod.csv |
| =250 | mg/kg bw/day | LEL | oral | Rat | ToxValDB_ToxRefDB |
| =250 | mg/kg bw/day | LEL | oral | rat (fischer; Fischer 344) | ToxRefDB_ToxRefDB_v3_pod.csv |
| - | unitless | Model Score | - | - | NTP_ICE_endocrine |
| 0.00583 | unitless | Model Score | - | - | NTP_ICE_endocrine |
| 0.0687 | unitless | Model Score | - | - | NTP_ICE_endocrine |
| 0.127 | unitless | Model Score | - | - | NTP_ICE_endocrine |
| >- | mg/kg bw/day | NEL | oral | mouse (b6c3f1; B6C3F1) | ToxRefDB_ToxRefDB_v3_pod.csv |
| =62.5 | mg/kg bw/day | NEL | oral | Mouse | ToxValDB_ToxRefDB |
| =62.5 | mg/kg bw/day | NEL | oral | rat (fischer; Fischer 344) | ToxRefDB_ToxRefDB_v3_pod.csv |
| =125 | mg/kg bw/day | NEL | oral | Rat | ToxValDB_ToxRefDB |
| =125 | mg/kg bw/day | NEL | oral | rat (fischer; Fischer 344) | ToxRefDB_ToxRefDB_v3_pod.csv |
| =31 | mg/kg bw/day | NOEL | - | - | INCHEM_WHO_jecfa_jecmono_v35je04 |
| =31 | mg/kg bw/day | NOEL | - | - | INCHEM_WHO_jecfa_jecmono_v35je04 |
| <62.5 | mg/kg bw/day | NOEL | oral | Rat | ToxValDB_HESS |
| 125 | mg/kg bw/day | Top dose | Gavage | Rat | NTP_ICE_cancer |
Showing 32 of 32 studies
Registration status from the ECHA REACH registered substances database.
| Status | Name | EC Number | Link |
|---|---|---|---|
| Registered | 4-hexylresorcinol | 205-257-4 | ECHA overview → |
Australian industrial chemicals inventory status and applicable conditions.
Same-CAS cosmetic ingredient record for cross-vertical context.
Same-CAS pharmaceutical records from drug and bioactivity sources.
Same-CAS food additive, ADI, and GRAS records where available.
E586 — ADI: 0.5 mg/kg bw
View full food safety profile →Same-CAS cannabis compliance and lab records where available.
1 cannabis record found in efsa substances.
View full cannabis profile →4-Hexylresorcinol has 32 NOAEL studies in the database. The lowest reported value is 0 unitless. Source: NTP_ICE_endocrine.
4-Hexylresorcinol appears on 2 regulatory/inventory lists including Canada; pharmaceutical, Canada; consumer_product; Substances in Products - Canada (4/2014). Source: EPA CPDat.
Yes, 4-Hexylresorcinol is also indexed as a cosmetic ingredient under the name Hexylresorcinol. View the full cosmetic safety profile on the ingredient page for detailed safety data, SCCS opinions, and regulatory status.
Safety data is sourced from EPA ToxValDB, EPA CPDat, AICIS (Australian Industrial Chemicals Introduction Scheme), EPA DSSTox, ECHA REACH, CosIng / Ingredients DB, ChEMBL / DailyMed, EFSA / FDA GRAS, cannabis regulatory/lab databases. All data traces to primary regulatory sources and is updated from official government databases.
4-Hexylresorcinol is classified GHS Danger (H302, H315, H319, H335, H360F) in the chemicals database but is allowed in EU cosmetics at max 20%.
4-Hexylresorcinol also appears in cosmetics, pharmaceutical, food safety, cannabis databases.